Johnson/NNP &/CC Johnson/NNP reported/VBD a/DT #/CD %/NN rise/NN in/IN third-quarter/JJ net/JJ income/NN on/IN a/DT #/CD %/NN sales/NNS increase/NN -/: results/NNS that/WDT were/VBD driven/VBN particularly/RB by/IN new/JJ products/NNS including/VBG pharmaceuticals/NNS and/CC the/DT company/NN 's/POS professional/JJ operations/NNS ./.
Net/NN for/IN the/DT New/NNP Brunswick/NNP ,/, N.J./NNP ,/, maker/NN of/IN health-care/NN products/NNS climbed/VBD to/TO $/$ #/CD million/CD ,/, or/CC #/CD cents/NNS a/DT share/NN ,/, from/IN $/$ #/CD million/CD ,/, or/CC #/CD cents/NNS a/DT share/NN ,/, in/IN the/DT year-earlier/JJ period/NN ./.
Sales/NNS rose/VBD to/TO $/$ #.#/CD billion/CD from/IN $/$ #.#/CD billion/CD ./.
The/DT year-ago/JJ per-share/JJ earnings/NNS are/VBP adjusted/VBN to/TO reflect/VB a/DT #-for-#/JJ stock/NN split/VBD last/JJ May/NNP ./.
In/IN a/DT statement/NN ,/, Ralph/NNP S./NNP Larsen/NNP ,/, chairman/NN and/CC chief/JJ executive/JJ officer/NN ,/, said/VBD the/DT company/NN was/VBD pleased/JJ with/IN its/PRP$ third-quarter/JJ sales/NNS performance/NN ,/, ``/`` especially/RB in/IN light/NN of/IN the/DT extremely/RB competitive/JJ environment/NN in/IN domestic/JJ consumer/NN markets/NNS and/CC the/DT negative/JJ impact/NN of/IN unfavorable/JJ exchange/NN rates/NNS this/DT quarter/NN ./. ''/''
David/NNP J./NNP Lothson/NNP ,/, an/DT industry/NN analyst/NN for/IN PaineWebber/NNP Group/NNP Inc./NNP ,/, said/VBD Johnson/NNP &/CC Johnson/NNP 's/POS results/NNS slightly/RB exceeded/VBD his/PRP$ expectations/NNS for/IN the/DT third/JJ quarter/NN ./.
In/IN New/NNP York/NNP Stock/NNP Exchange/NNP composite/NN trading/VBG yesterday/NN ,/, Johnson/NNP &/CC Johnson/NNP shares/NNS fell/VBD #.#/CD cents/NNS to/TO $/$ #.#/CD ./.
Mr./NNP Larsen/NNP noted/VBD ``/`` substantial/JJ sales/NNS growth/NN ''/'' for/IN the/DT recently/RB introduced/VBN Acuvue/NNP disposable/JJ contact/NN lens/NN and/CC Hismanal/NNP ,/, a/DT once-a-day/JJ antihistamine/NN ./.
Eprex/NNP ,/, used/VBN by/IN dialysis/NN patients/NNS who/WP are/VBP anemic/JJ ,/, and/CC Prepulsid/NN ,/, a/DT gastro-intestinal/JJ drug/NN ,/, did/VBD well/RB overseas/RB ,/, he/PRP said/VBD ./.
Despite/IN health-care/NN cost/NN controls/NNS and/CC programs/NNS to/TO hold/VB down/RP inventory/NN ,/, the/DT professional/JJ division/NN ,/, which/WDT makes/VBZ products/NNS including/VBG sutures/NNS and/CC surgical/JJ stapling/NN equipment/NN ,/, ``/`` achieved/VBD solid/JJ growth/NN ,/, ''/'' Johnson/NNP &/CC Johnson/NNP said/VBD ./.
But/CC domestic/JJ consumer/NN sales/NNS slipped/VBD #.#/CD %/NN for/IN the/DT quarter/NN ,/, to/TO $/$ #/CD million/CD from/IN $/$ #/CD million/CD ./.
The/DT company/NN cited/VBD softness/NN in/IN the/DT retail/JJ health/NN and/CC beauty/NN aids/NNS category/NN ,/, ``/`` as/RB well/RB as/IN the/DT intense/JJ competition/NN in/IN the/DT company/NN 's/POS sanitary/JJ protection/NN product/NN line/NN ./. ''/''
Overseas/JJ sales/NNS were/VBD stronger/JJR ,/, principally/RB because/IN of/IN a/DT rebound/NN in/IN Brazil/NNP ,/, where/WRB economic/JJ turmoil/NN had/VBD hurt/VBN year-earlier/JJ results/NNS ,/, Johnson/NNP &/CC Johnson/NNP said/VBD ./.
Mr./NNP Lothson/NNP of/IN PaineWebber/NNP said/VBD the/DT company/NN 's/POS sales/NNS pace/NN has/VBZ been/VBN picking/VBG up/RP largely/RB because/IN the/DT effect/NN of/IN unfavorable/JJ exchange/NN rates/NNS has/VBZ been/VBN easing/VBG --/: a/DT pattern/NN continuing/VBG this/DT quarter/NN ./.
He/PRP cautioned/VBD ,/, however/RB ,/, that/IN a/DT ``/`` tough/JJ tax-rate/NN comparison/NN ''/'' may/MD slow/VB the/DT company/NN 's/POS earnings/NNS growth/NN for/IN the/DT current/JJ quarter/NN ./.
For/IN last/JJ year/NN 's/POS fourth/JJ quarter/NN ,/, the/DT company/NN 's/POS tax/NN rate/NN was/VBD less/JJR than/IN #/CD %/NN ,/, he/PRP said/VBD ./.
While/IN the/DT third/JJ period/NN contained/VBD no/DT major/JJ surprises/NNS ,/, Mr./NNP Lothson/NNP said/VBD ,/, the/DT results/NNS show/VBP how/WRB sensitive/JJ the/DT multinationals/NNS can/MD be/VB to/TO developments/NNS in/IN a/DT single/JJ country/NN such/JJ as/IN Brazil/NNP ./.
He/PRP also/RB questioned/VBD whether/IN recent/JJ gains/NNS in/IN that/DT country/NN can/MD be/VB sustained/VBN ./.
The/DT following/JJ issues/NNS were/VBD recently/RB filed/VBN with/IN the/DT Securities/NNP and/CC Exchange/NNP Commission/NNP :/:
Bergen/NNP Brunswig/NNP Corp./NNP ,/, proposed/JJ offering/NN of/IN liquid/JJ yield/NN option/NN notes/NNS ,/, via/IN Merrill/NNP Lynch/NNP Capital/NNP Markets/NNP ./.
Columbia/NNP Gas/NNP System/NNP Inc./NNP ,/, shelf/NN offering/NN of/IN up/IN to/TO $/$ #/CD million/CD of/IN debentures/NNS ./.
Laserscope/NNP ,/, initial/JJ offering/NN of/IN #,#,#/CD common/JJ shares/NNS ,/, of/IN which/WDT #,#,#/CD shares/NNS are/VBP to/TO be/VB sold/VBN by/IN the/DT company/NN and/CC #,#/CD by/IN holders/NNS ,/, via/IN Alex/NNP ./. Brown/NNP &/CC Sons/NNP Inc./NNP and/CC Volpe/NNP ,/, Covington/NNP &/CC Welty/NNP ./.
TeleVideo/NNP Systems/NNP Inc./NNP ,/, proposed/JJ offering/NN of/IN #,#,#/CD common/JJ shares/NNS ,/, to/TO be/VB sold/VBN by/IN holders/NNS ./.
Western/NNP Gas/NNP System/NNP Inc./NNP ,/, initial/JJ offering/NN of/IN #,#,#/CD common/JJ shares/NNS ,/, of/IN which/WDT #,#,#/CD shares/NNS will/MD be/VB sold/VBN by/IN the/DT company/NN and/CC #,#/CD by/IN a/DT holder/NN ,/, via/IN Prudential-Bache/NNP Capital/NNP Funding/NNP ,/, Smith/NNP Barney/NNP ,/, Harris/NNP Upham/NNP &/CC Co./NNP and/CC Hanifen/NNP ,/, Imhoff/NNP Inc/NNP ./.
